Page last updated: 2024-11-05

ici 204,219 and Erythema Nodosum

ici 204,219 has been researched along with Erythema Nodosum in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Erythema Nodosum: An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vides, EA1
Cabrera, A1
Ahern, KP1
Levis, WR1

Trials

1 trial available for ici 204,219 and Erythema Nodosum

ArticleYear
Effect of zafirlukast on leprosy reactions.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1999, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Clofazimine; Cohort Studies; D

1999